摘要
目的用人血清清蛋白免疫损伤Wistar大鼠造成肝纤维化模型,观察中药抑肝纤和促肝细胞生长素对大鼠肝纤维化的阻断作用.方法将不同浓度(含生药12kg/L或24kg/L两种)中药抑肝纤(主要含黄芪,丹参,鳖甲,牡蛎等)和促肝细胞生长素用于治疗组并与模型组和对照组进行对比,综合分析血清肝纤维化指标(PCⅢ,HA,LN)、肝组织病理改变、肝组织胶原纤维和网状纤维病理图象定量分析等结果.结果治疗组血清肝纤维化指标PCⅢ(μg/L;12kg/L组为924±252vs1596±370,P<001)HA(μg/L;12kg/L组为2437±1068vs4812±1211,P<001)LN(μg/L;12kg/L组为889±264vs1423±544,P<001)均低于模型组,接近正常组(三项指标分别为916±326,2366±1212及925±235)差异有显著性.光镜下肝组织病理变化,肝组织中胶原纤维和网状纤维病理图象定量分析结果治疗组优于模型组,尤以中药低浓度组更为明显(P<001或P<005).结论研究结果表明,中药抑肝纤和促肝细胞生长素如能早期应用,可有效地阻?
IM To study the blocking effects of traditional Chinese herbs Yiganxian and promoting hepatocyte growth factor (PHGF) on immunodamaged liver fibrosis in rats.METHODS Abstract:Treatment groups with various doses (including dried medicinal herbs (12kg/L or 24kg/L) traditional Chinese herbs Yiganxian and PHGF were compared with model group and control group. Serum PCⅢ, HA and LN, pathological changes of hepatic tissues, and results of collagenous fibers and reticular fibers pathological picture of the liver were analyzed.RESULTS Serum PCⅢ (μg/L; in the 12kg/L group 924±252 vs 1596±370,P<001) HA (μg/L; 2437±1068 vs 4812±1211,P<001) LN (μg/L; 889±264 vs 1423±544,P<001) in the treatment group were obviously lower than model group,and close to control group (μg/L; 916±326, μg/L 2366±1212, μg/L; 925±235). Pathological results under microscope and results of collagenous and reticular fibers pathological picture in the liver were better than model group especially in the group of lowdose traditional Chinese herbs (P<001/P<005).CONCLUSION Early administration of traditional Chinese herbs Yiganxian and PHGF can effectively prevent liver fibrosis in rats.
关键词
肝硬化
中西医结合治疗
肝细胞生长因子
liver cirrhosis, experimental/therapy
hepatocyte growth factor/administration and dosage
Astragalus Membranaceus/administration and dosage
Salvia Miltiorrhiza/administration and dosage
rats, Wistar